ST
AKRO

Skorpios Trust’s Akero Therapeutics AKRO Stock Holding History

Skorpios Trust’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,621,829
Closed -$75.7M – 3
2023
Q2 		$75.7M Sell
1,621,829
-1,650,000
-50% -$75.6M 32.88% 2
2023
Q1 		$125M Hold
3,271,829
– – 50.58% 1
2022
Q4 		$179M Sell
3,271,829
-1,636,000
-33% -$70.1M 57.03% 1
2022
Q3 		$167M Hold
4,907,829
– – 47.17% 2
2022
Q2 		$46.4M Hold
4,907,829
– – 19.41% 2
2022
Q1 		$69.6M Hold
4,907,829
– – 18.54% 2
2021
Q4 		$104M Buy
+4,907,829
New +$109M 22.97% 2

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Skorpios Trust's AKRO Position: Q3 2023 in Review

Skorpios Trust sold out of Akero Therapeutics (AKRO) in Q3 2023, closing a stake of 1,621,829 shares — an estimated $75.7M sold.

Skorpios Trust first reported a position in AKRO in Q4 2021 and held it in 7 quarters. The position peaked at $179M in Q4 2022. 181 funds tracked by Wall St. Rank hold AKRO as of Q3 2023.

  • Skorpios Trust reported no remaining Akero Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Skorpios Trust sold 1,621,829 Akero Therapeutics shares in Q3 2023, an estimated $75.7M.
  • Skorpios Trust first reported a position in Akero Therapeutics in Q4 2021 and held it in 7 quarters.
  • Skorpios Trust's Akero Therapeutics position peaked at $179M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Akero Therapeutics as of Q3 2023.

Based on Skorpios Trust's 13F filing for Q3 2023, filed 6 Nov 2023.